Press Release PR9.NET
Home Submit Press Release Search Archives
Press Release
Advanced Search

Science Science
Agriculture, Biology
Chemistry, Physics
Conferences, Space
Earth Sciences, Social
Electronics, Philosophy

Business Business
Computers Computers
Entertainment Entertainment
Games Games
Health Health
Home Home
Sports Sports
Society Society
Teens Teens
Press Release Category Science - Chemistry - Affinity Life Sciences Release Date: January 16, 2015


By Affinity Life Sciences
January 16, 2015
Send SEND Print PRINT Download PDF Version PDF Contact Affinity Life Sciences CONTACT

SRC Acumen announced the continued and exclusive production of lyophilized qPCR and toxin assays by Affinity Life Sciences.

PR9.NET January 16, 2015 - Affinity Life Sciences, Inc. and SRC Acumen, LLC are announcing the continued production of freeze-dried qPCR and toxin assays. As part of this agreement, Affinity Life Sciences will manufacture these products exclusively for SRC Acumen.

SRC Acumen?s assays are unique in their ability to provide near real-time, interferent resistant, one-step identification of pathogens and toxins. They are used to support government and commercial customers with food, water, and public health monitoring; homeland security; biosurveillance; and chemical and biological defense.

Specific assays being produced include the Acu-Bot?, Acu-Ricin? and Acu-PAPA? SEB toxin assays for the identification of biologically active Botulinum neurotoxin (BoNT) A, Ricin, and Staphylococcus enterotoxin B (SEB). The qPCR assays include specific chemistries for the identification of Bacillus anthracis, Francisella tularensis, Yersinia pestis, Coxiella burnetti, Brucella spp., PanOrthopox and VEE viruses.

Paul G. Tremont, president of SRC said, ?We required a teammate with the expertise needed to produce these important assays to ensure the highest quality for our customers. This collaboration with Affinity Life Sciences provides us with the capabilities needed for lyophilization, also known as freeze-drying, biomarker assay and quality control development and production.

"We are delighted to be able to work with SRC", said Tod Gavron, president of Affinity Life Sciences. SRC is expanding the limits of what's possible in biodefense threat identification, advancing assay technologies that deliver fast, reliable and relevant information. Their assays are valuable tools for critical decision makers in the field.?

# # #

Contact Information of Affinity Life Sciences Contact Information of Affinity Life Sciences
Phone (603) 718-1790
E-Mail E-mail Address Protected
Address 10 Columbia Drive
Amherst, NH 03031

About SRC Acumen, LLC

SRC Acumen, LLC is a subsidiary of SRC, Inc., a not-for-profit research and development company with more than 55 years of experience in defense, environment and intelligence. SRC Acumen is focused on bringing chem-bio threat identification and detection capabilities to the commercial and civilian government marketspaces. For more information about SRC Acumen and their product catalog, please visit For more information about SRC, Inc, visit

About Affinity Life Sciences

Affinity Life Sciences is a contract manufacturing organization committed to providing scientific and quality expertise to meet the lyophilization and production demands of our customers. Our unique services offer our customers a single source for identifying and supplying raw materials, product and process development, manufacturing capabilities, and quality services.

Recent News Headlines
More Press Releases
Industry Category of Current Press Release
    Copyright © 2004 - 2014 PR9.NET - All rights reserved RSS Feeds Submit Press Release Terms of Service Privacy Policy